ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HCM Hutchmed (china) Limited

310.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 310.00 307.00 310.00 314.00 303.00 311.00 17,440 16:35:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0
Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 310p. Over the last year, Hutchmed (china) shares have traded in a share price range of 173.60p to 338.00p.

Hutchmed (china) currently has 871,256,270 shares in issue.

Hutchmed (china) Share Discussion Threads

Showing 3301 to 3323 of 4100 messages
Chat Pages: Latest  140  139  138  137  136  135  134  133  132  131  130  129  Older
DateSubjectAuthorDiscuss
12/6/2021
11:05
Thanks CT. Like every other follower of this message board, keenly looking forward for the day Hutchmed gets listed on HKSE (and Shanghai) SE and also how different HCM shares will be linked pari-passu in value.
sportii
12/6/2021
09:13
Sportii, I assume a young journalist have their finger on the pulse. Are IFR a reputable source? Well they are under the Refinitiv umbrella, which most people are aware are owned by the London Stock Exchange.
cockneytrader
12/6/2021
07:43
What is the reason for such vital information not getting covered anywhere else, including the company’s website? How come only ifre gets to know the information from ‘people with the knowledge of the matter’?
sportii
11/6/2021
17:46
Asian listing gets green light

hxxps://www.ifre.com/story/2913224/hutchmed-china-wins-nod-for-hk-listing-1hzffmdmnb

cockneytrader
09/6/2021
18:16
"said people with knowledge of the matter."

"said the people."

nerdofsteel
09/6/2021
12:00
Yes I did see that post BUT you will be aware that the earlier post doesn't open up like the link I kindly provided.My wish is to be of service
steeplejack
09/6/2021
10:20
Did you see the post before yours steeplejack? Over a day earlier and the same information LOL!

Let's hope for some confirmation of this from the BOD now. Here is the link in an active format too. Only need to edit the lower-case "h" to an upper-case "H" to make links work.

lauders
09/6/2021
07:23
https://www.ifre.com/story/2905643/hutchmed-targets-hk-listing-approval-this-week-bbgbstxjrn
steeplejack
07/6/2021
22:56
No smoke without fire

hxxps://www.ifre.com/story/2905643/hutchmed-targets-hk-listing-approval-this-week-bbgbstxjrn

cockneytrader
07/6/2021
21:27
Been thinking that for ages.
its the oxman
07/6/2021
17:45
Listing in Asia is imminent.
cockneytrader
04/6/2021
13:29
Whatja,
I think that this is what is behind HM's strategy for designing small molecule drugs that will be used in combination to enhance the efficiency of existing drugs and also the focus on low toxicity for new drugs that will differentiate them.

dbadvn
04/6/2021
13:06
HCM got in last week rather than get lost in the noise from the bigger boys.
AZ has published some great papers....it is easy to get lost in the technicalities but what ASCO ESMO etc tell me is that cures for cancers are getting better.
It will take longer to prove new drugs are better than existing standard of care, so we will see fragmentation of the market so that each expensive drug has its own core zone of effectiveness where it will dominate but these will get narrower.

whatja
04/6/2021
11:17
ASCO begins today - usually get a boost at this time
nerdofsteel
03/6/2021
07:09
now that's an interesting thought Whatja! I did notice on the Asian Investor call when asked a question about possible listings CH immediately shut down the conversation "I am not going to comment on any possible Equity Capital Market activity"

That implied something is going on

nerdofsteel
02/6/2021
12:18
BTW I have seen that CK Life Sciences has popped 28% today in HK..there is no RNS equivalent.

CKHH to combine Life sciences and Hutchmed? And generate HK listing?
CKLS has a value of about £900m

whatja
02/6/2021
11:07
I have long thought AIM needs a revamp....promotion to the main board should be compulsory once the map is above the ftse350 entry point for a given period. While it would reduce the AIM market it would encourage stewardship aligned with the value of the organisation.
I suspect that many smaller companies would be better off on AIM..

whatja
02/6/2021
11:05
I’ve sold 2/3 over last week, had a great run as I’ve held since 2014 buying initially @115p. Still think it’s a good company but there are better risk/reward opportunities out there now.
rabiddog
02/6/2021
10:44
Which is exactly why we need a main board UK listing and an Asian listing.
dbadvn
02/6/2021
10:34
In "theory" hitting $1bn in annual revenues and becoming profitable should attract a mcap of $20bn, possibly more, based on average P/S and other metrics for the sector but who knows! The Company's valuation has tripled in a year on more than one occasion in the past so it's possible if we get a significant new pool of investors.
nerdofsteel
01/6/2021
14:57
Steadied the ship

It appears last week’s presentation has firmed up the share price with promises of a rich pipeline to drive a rapid commercialisation phase.

There are still lots of regulatory hurdles to clear but the data presented looks promising.

The US share price went through $30 a short while ago....the sinking feeling of a few weeks ago seems a distant memory.

A doubling of the Market capitalisation with the 2025 targets being met seems quite possible. Atleast that is why I have my holding.

whatja
28/5/2021
05:56
NASDAQ yesterday:-
Volume 647,090
Avg. volume 232,040

nerdofsteel
27/5/2021
16:37
CH was very firm, he would NOT comment on any possible equity raising.....

"I'm not gonna comment on specific equity capital market activities"

nerdofsteel
Chat Pages: Latest  140  139  138  137  136  135  134  133  132  131  130  129  Older

Your Recent History

Delayed Upgrade Clock